G1 Therapeutics, Inc.
PYRIMIDINE-BASED ANTIPROLIFERATIVE AGENTS
Last updated:
Abstract:
This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
Status:
Application
Type:
Utility
Filling date:
3 Nov 2020
Issue date:
18 Feb 2021